Director, Access Strategy, Portfolio and Pipeline Innovation

We are ViiV Healthcare, a pharmaceutical company solely focused on combating, preventing, and ultimately eradicating HIV and AIDS.

The Director, Access Strategy, Portfolio and Pipeline Innovation will serve as the US Market Access strategic lead for selected in-line portfolio initiatives, including loss-of-exclusivity and other lifecycle transitions, and for selected pre-launch pipeline assets.

Responsibilities

• Lead US market access strategy for assigned portfolio and lifecycle priorities, including loss-of-exclusivity, indication expansion, formulation or dosing evolution, and other events that could materially affect access, reimbursement, or portfolio value.
• Serve as the US Market Access lead for assigned early- and late-stage pipeline assets, embedding payer, purchaser, provider, channel, and patient-access insights into development and commercialization strategies.
• Establish a structured process to monitor, assess, and communicate external developments that could affect ViiV’s portfolio, including government pricing policy, Medicaid eligibility and financing changes, PBM and payer-model evolution, reimbursement reform, and channel consolidation.

Basic Qualifications

• Bachelor’s degree and 5+ years of pharmaceutical, biotechnology, payer, and consulting experience OR healthcare experience
• Experience developing market access strategy for lifecycle, pipeline, launch, policy, pricing, reimbursement, or portfolio initiatives.
• Experience with both commercial and government payer segments, including PBMs, health plans, employers, Medicaid, and Medicare.

Preferred Qualification

• Advanced degree in business, public health, health economics, pharmacy, public policy, or a related discipline.
• 3+ years of experience in Market Access.
• Experience in or understanding of the HIV therapeutic area

Benefits

• Comprehensive benefits program, including options and plans similar to GSK employee benefits